Sumithira Vasu

机构：The Ohio State University · ORCID：0000-0002-8635-3880

发表论文 235 篇 · 总被引 2653 次 · h-index 23

代表论文

• Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT (2025 · Blood · 被引 28)
• Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies (2025 · Journal of Hematology & Oncology · 被引 14)
• High incidence of severe TA-TMA increases mortality in adult allogeneic transplant recipients: a prospective MIDAS Consortium study (2025 · Blood · 被引 12)
• An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy (2025 · Transplantation and Cellular Therapy · 被引 8)
• First‐line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trial (2025 · British Journal of Haematology · 被引 3)
• Presence of Clonal Hematopoiesis and Cardiac Events After Allogeneic Stem Cell Transplantation (2025 · Journal of the American Heart Association · 被引 3)